US vaccine maker Moderna set to sign US$1 billion Shanghai deal in major inroad into China’s healthcare market

The maker of the mRNA Covid-19 vaccine is expected to sign an agreement with Shanghai government as early as Wednesday, with the investment going towards vaccine development and manufacturing, according to sources.

Read the original article at South China Morning Post